Machina Capital S.A.S. Alnylam Pharmaceuticals, Inc. Transaction History

Machina Capital S.A.S.

  • $238 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$143.31 - $247.0 $611,360 - $1.05 Million
4,266 New
4,266 $1.04 Million
Q2 2023

Aug 08, 2023
BUY
$185.01 - $212.05 $244,953 - $280,754
1,324 New
1,324 $251,000
Q3 2022

Nov 10, 2022
BUY
$138.54 - $232.0 $237,873 - $398,344
1,717 New
1,717 $344,000

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Machina Capital S.A.S. Portfolio

Follow Machina Capital S.A.S. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Machina Capital S.A.S., based on Form 13F filings with the SEC.

News

Stay updated on Machina Capital S.A.S. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email